FDA Device Center Touts Clinical Trial Review Performance
This article was originally published in The Gray Sheet
Executive Summary
According to the latest numbers, CDRH says it has reduced median investigational review exemption review times to 30 days, and three out of four IDEs are now fully approved after two review cycles.